TrialInvestigational new drugs2014

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors.

Robin L Jones et al.PubMed ↗Publisher ↗

No numbers read from the abstract.